Tunable expression of genes in the brain
| Reference number | |
| Coordinator | GENETUNES AB |
| Funding from Vinnova | SEK 299 000 |
| Project duration | May 2017 - February 2018 |
| Status | Completed |
| Venture | Innovative Startups |
| Call | Innovativa startups fas 1 Våren 2017 |
Important results from the project
To increase the competitiveness of the technology for funding and further development in cooperation with investors and industry.
Expected long term effects
We have accomplished our objectives.
Approach and implementation
We did a thorough investigation of the stakeholders within the market för gene therapies and selected the ones that we deemed most interested in our specific type of technology and initiated contacts. Under the discussions with them, we verified the competitiveness of our technology, our freedom to operate and next necessary steps.